VANCOUVER, British Columbia (GenomeWeb) – Illumina announced yesterday that it has submitted more than 95,000 human genetic variants to the National Center for Biotechnology Information (NCBI)'s open-access ClinVar database.

The variants were identified in individuals undergoing TruGenome predisposition testing or TruGenome undiagnosed disease testing at the company's CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory, Ryan Taft, senior director of scientific research, told GenomeWeb at the American Society of Human Genetics annual meeting.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.

Dec
05
Sponsored by
Agilent

This webinar will discuss a molecular barcode-based error correction method that enables combined mutation detection and DNA copy number profiling through circulating tumor DNA sequencing.